Johnson,Peter W M

Institution: University of Manchester, UK

Research Interests: Chemotherapy, Lymphoma, Patients, Serum, Administration, B-cell, B-cell Lymphoma, Half-life, Radioimmunoconjugate, Radioimmunotherapy, Tumor, Hodgkin Lymphoma, Bleomycin, Dacarbazine, Doxorubicin, Hodgkins Lymphoma, Vinblastine, Antibodies, Concentration, Elisa